CDH22 and cancer: Cadherin-22, a cell-cell adhesion molecule, is upregulated by promoter eIF4E2-mediated mTORC1-independent translational control during hypoxia; the novel function of cadherin-22 acts as a hypoxia-specific cell surface molecule and is involved in cancer cell migration, invasion, and adhesion [44].